Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarjinder Sahota

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|July 11, 2012
Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosisTarjinder Sahota, Oscar Della Pasqua
Mutagenesis|March 13, 2016
Pharmacology-based toxicity assessment: towards quantitative risk prediction in humansTarjinder Sahota, Meindert Danhof, Oscar Della Pasqua
Journal of Pharmacokinetics and Pharmacodynamics|April 15, 2015
The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experimentsTarjinder Sahota, Meindert Danhof, Oscar Della Pasqua
British Journal of Pharmacology|April 18, 2015
Model-based prediction of the acute and long-term safety profile of naproxen in ratsTarjinder Sahota, Ian Sanderson, Meindert Danhof, et al.
Toxicology and Applied Pharmacology|March 27, 2014
Model-based analysis of thromboxane B₂ and prostaglandin E₂ as biomarkers in the safety evaluation of naproxenTarjinder Sahota, Ian Sanderson, Meindert Danhof, et al.
The AAPS Journal|March 18, 2021
Parent and Metabolite Concentration-QT Modeling to Evaluate QT-Interval Prolongation at Savolitinib Therapeutic DosesStein Schalkwijk, Tarjinder Sahota, Remy B Verheijen, et al.
Journal of Personalized Medicine|December 24, 2021
Imputing Biomarker Status from RWE Datasets-A Comparative StudyCarlos Traynor, Tarjinder Sahota, Helen Tomkinson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug ToxicologyAlienor Berges, Marc Cerou, Tarjinder Sahota, et al.
Toxicology and Applied Pharmacology|August 2, 2015
Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug developmentAnaïs Glatard, Aliénor Berges, Tarjinder Sahota, et al.
Cancer Research|May 6, 2015
Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in OncologyNúria Buil-Bruna, Tarjinder Sahota, José-María López-Picazo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|July 11, 2012
Feasibility of a fixed-dose regimen of pyrazinamide and its impact on systemic drug exposure and liver safety in patients with tuberculosisTarjinder Sahota, Oscar Della Pasqua
Mutagenesis|March 13, 2016
Pharmacology-based toxicity assessment: towards quantitative risk prediction in humansTarjinder Sahota, Meindert Danhof, Oscar Della Pasqua
Journal of Pharmacokinetics and Pharmacodynamics|April 15, 2015
The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experimentsTarjinder Sahota, Meindert Danhof, Oscar Della Pasqua
British Journal of Pharmacology|April 18, 2015
Model-based prediction of the acute and long-term safety profile of naproxen in ratsTarjinder Sahota, Ian Sanderson, Meindert Danhof, et al.
Toxicology and Applied Pharmacology|March 27, 2014
Model-based analysis of thromboxane B₂ and prostaglandin E₂ as biomarkers in the safety evaluation of naproxenTarjinder Sahota, Ian Sanderson, Meindert Danhof, et al.
The AAPS Journal|March 18, 2021
Parent and Metabolite Concentration-QT Modeling to Evaluate QT-Interval Prolongation at Savolitinib Therapeutic DosesStein Schalkwijk, Tarjinder Sahota, Remy B Verheijen, et al.
Journal of Personalized Medicine|December 24, 2021
Imputing Biomarker Status from RWE Datasets-A Comparative StudyCarlos Traynor, Tarjinder Sahota, Helen Tomkinson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 23, 2018
Time-to-Event Modeling of Left- or Right-Censored Toxicity Data in Nonclinical Drug ToxicologyAlienor Berges, Marc Cerou, Tarjinder Sahota, et al.
Toxicology and Applied Pharmacology|August 2, 2015
Comparing probabilistic and descriptive analyses of time-dose-toxicity relationship for determining no-observed-adverse-effect level in drug developmentAnaïs Glatard, Aliénor Berges, Tarjinder Sahota, et al.
Cancer Research|May 6, 2015
Early Prediction of Disease Progression in Small Cell Lung Cancer: Toward Model-Based Personalized Medicine in OncologyNúria Buil-Bruna, Tarjinder Sahota, José-María López-Picazo, et al.
Pageof 2